Posted on May 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on April 20, 20224/20/22
Navigating the Complexities of Patient Care with Digital and Human Touchpoints
Posted on April 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on April 6, 20224/6/22
Reframing the Challenges of Access and ROI
Posted on March 24, 20223/24/22
New Legislation Supports Payment for Digital Therapeutics
Posted on March 2, 20223/2/22
Succeed When Others Fail: Avoiding 20% in Investment Waste During Launch
Posted on January 28, 20221/28/22
How to Ensure Speed and Efficiency When Launching in Europe
Posted on January 20, 20221/20/22
A Holistic Launch in Europe Is Possible, But Change Is Necessary
Posted on December 22, 202112/22/21
Why Launching in Europe Is Unlike Launching Anywhere Else
Posted on December 20, 202112/20/21